Éva Csősz

Dr. Éva Csősz

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Journal of Proteomics
Verified
Journal Article
Closed access
Éva CsőszÉva Csősz
Éva Csősz
PBPéter Boross
Péter Boross
ACAdrienne Csutak
Adrienne Csutak
ABAndrás Berta
András Berta
TFTóth Ferenc
Tóth Ferenc
JTJozsef Tozser
Jozsef Tozser

21 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GKGergő Kalló
Gergő Kalló
MEMiklós Emri
Miklós Emri
ZVZsófia Varga
Zsófia Varga
BUBernadett Ujhelyi
Bernadett Ujhelyi
JTJózsef Tőzsér
József Tőzsér
Éva CsőszÉva Csősz
Éva Csősz
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases, with increasing prevalence affecting millions of people worldwide. Currently, only autopsy is able to confirm the diagnosis with a 100% certainty, therefore, biomarkers from body fluids obtained by non-invasive means provide an attractive alternative for the diagnosis of Alzheimer`s disease. Global changes of the protein profile were examined by quantitative proteomics; firstly, electrophoresis and LC-MS/MS were used, thereafter, SRM-based targeted proteomics method was developed and applied to examine quantitative changes of tear proteins. Alterations in the tear flow rate, total tear protein concentration and composition of the chemical barrier specific to AD were demonstrated, and the combination of lipocalin-1, dermcidin, lysozyme-C and lacritin was shown to be a potential biomarker, with an 81% sensitivity and 77% specificity.

16 November 2009 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
RKRobert Kiraly
Robert Kiraly
Éva CsőszÉva Csősz
Éva Csősz
TKTibor Kurtàn
Tibor Kurtàn
SASándor Antus
Sándor Antus
KSKrisztián Szigeti
Krisztián Szigeti
LFLászló Fésüs
László Fésüs
The multifunctional tissue transglutaminase 2 (TG2) has a four‐domain structure with several Ca2+‐regulated biochemical activities, including transglutamylation and GTP hydrolysis. The structure of the Ca2+‐binding form of the human enzyme is not known, and its Ca2+‐binding sites have not been fully characterized. By mutagenesis, we have targeted its active site Cys, three sites based on homology to Ca2+‐binding residues of epidermal transglutaminase and factor XIIIa (S1–S3), and two regions with negative surface potentials (S4 and S5). CD spectroscopy, antibody‐binding assay and GTPase activity measurements indicated that the amino acid substitutions did not cause major structural alterations. Calcium‐45 equilibrium dialysis and isothermal calorimetric titration showed that both wild‐type and active site‐deleted enzymes (C277S) bind six Ca2+. Each of the S1–S5 mutants binds fewer than six Ca2+, S1 is a strong Ca2+‐binding site, and mutation of one site resulted in the loss of more than one bound Ca2+, suggesting cooperativity among sites. All mutants were deficient in transglutaminase activity, and GTP inhibited remnant activities. Like those of the wild‐type enzyme, the GTPase activities of the mutants were inhibited by Ca2+, except in the case of the S4 and S5 mutants, which exhibited increased activity. TG2 is the major autoantigen in celiac disease, and testing the reactivity of mutants with autoantibodies from celiac disease patients revealed that S4 strongly determines antigenicity. It can be concluded that five of the Ca2+‐binding sites of TG2 influence its transglutaminase activity, two sites are involved in the regulation of GTPase activity, and one determines antigenicity for autoantibodies in celiac patients.

1 February 2017 in Journal of Proteomics
Verified
Journal Article
Closed access
Éva CsőszÉva Csősz
Éva Csősz
GKGergő Kalló
Gergő Kalló
BMBernadett Márkus
Bernadett Márkus
EDEszter Deák
Eszter Deák
ACAdrienne Csutak
Adrienne Csutak
JTJozsef Tozser
Jozsef Tozser

25 August 2015 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Éva CsőszÉva Csősz
Éva Csősz
GEG. Emri
G. Emri
GKG. Kalló
G. Kalló
GTG. Tsaprailis
G. Tsaprailis
JTJozsef Tozser
Jozsef Tozser

18 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Éva CsőszÉva Csősz
Éva Csősz
PLPéter Lábiscsák
Péter Lábiscsák
GKGergő Kalló
Gergő Kalló
BMBernadett Márkus
Bernadett Márkus
MEMiklós Emri
Miklós Emri
IMIldikó Judit Márton
Ildikó Judit Márton
Oral squamous cell carcinoma (OSCC) accounting for about 90% of malignant oral lesions is the 6th most common malignancy worldwide. Diagnostic delay may contribute to dismal survival rate therefore, there is a need for developing specific and sensitive biomarkers to improve early detection. Hungarian population occupies the top places of statistics regarding OSCC incidence and mortality figures therefore, we aimed at finding potential salivary protein biomarkers suitable for the Hungarian population. In this study we investigated 14 proteins which were previously reported as significantly elevated in saliva of patients with OSCC. In case of IL-1α, IL-1β, IL-6, IL-8, TNF-α and VEGF a Luminex-based multiplex kit was utilized and the salivary concentrations were determined. In case of catalase, profilin-1, S100A9, CD59, galectin-3-bindig protein, CD44, thioredoxin and keratin-19, SRM-based targeted proteomic method was developed and the relative amount of the proteins was determined in the saliva of patients with OSCC and controls. After several rounds of optimization and using stable isotope-containing peptides, we developed an SRM-based method for rapid salivary protein detection. The validation of the selected potential biomarkers by ELISA revealed salivary protein S100A9 and IL-6 as useful protein biomarkers for OSCC detection improving the diagnostic accuracy for OSCC in the Hungarian population.A noninvasive diagnostic method to detect biomarkers useful for the early diagnosis of OSCC was developed. This can be an attractive strategy in screening saliva samples collected in a nation-wide multi-centric study in order to decrease morbidity, mortality, to enhance survival rate and to improve quality of life. The heterogeneity of protein biomarkers found in different ethnic groups presented in the literature highlights the importance of identification of population-tailored protein biomarkers.